NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/11/2024
Voltar para busca
Dado oficial do USPTO
QVEQLI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
26/11/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10
Data de depósito
18/06/2020
Data de registro
26/11/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/11/2024
Última transação
26/11/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Hellerup, DK
Examinador
ADORNO SANTOS, LUZ
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Ascendis Pharma Endocrinology Division A/S
Representantes
Shannon Marie McKeon DYKEMA GOSSETT PLLC
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of growth disorderspharmaceutical preparations for the treatment of endocrine disorderspharmaceutical preparations for the treatment of bone disorderspharmaceutical preparations for the treatment of cancerpharmaceutical preparations for the treatment of infectious diseases; diagnostic preparations for medical purposesdiagnostic preparations for identifying and detecting growth hormone deficiencyendocrine disordersbone disorderscancerinfectious diseases
Classe 9
Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatmentpatient assistance and health insurance in the field of growth disordersendocrine disordersbone disorderscancerinfectious diseases; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersa downloadable software application for sharing information related to growth disordersendocrine disordersbone disorderscancerinfectious diseases and the treatment of growth disordersendocrine disordersbone disorderscancerinfectious diseases for use by patients with growth hormone disordershypoparathyroidismskeletal dysplasiadiabetes in the medical field of growth disordersendocrine disordersbone disorderscancerinfectious diseases; downloadable computer application software for mobile phonestablet computers handheld computers and personal computersdownloadable software that coordinates the delivery of health care services between health care providerspatients and those parties responsible for the payment of health care servicesdownloadable software that allows individuals seeking medical educationinformation and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersdownloadable software that enables health care providers to monitor patientscommunicate clinical information relevant to a patient's careprovide and exchange information concerning patients and the health care services provided to patients; downloadable softwaredownloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable softwaredownloadable software applications and downloadable mobile applications for the measurement of heightweightblood pressureserum calciumblood glucoseheart rate; downloadable softwaredownloadable software applications and downloadable mobile applications for providingexchangingretrieving and analyzing health and healthcare information; downloadable software for medical purposesfor formattingviewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersa downloadable software application for providing healthcare-related informationmedication reminderstracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of growth disordersendocrine disordersbone disorderscancerinfectious diseases
Classe 10
Medical devices for injectiondosage and control of pharmaceuticalsmedical devices for injectiondosage measurement and monitoring of pharmaceuticals for the treatment of growth disordersendocrine disordersbone disorderscancerinfectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical usesyringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disordershypoparathyroidismskeletal dysplasiacancer and diabetes; medical apparatusinfusion and injection devices for administering drugs; medical apparatus for diagnostic purposesmedicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
26/11/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
04/11/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
30/10/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
16/05/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
16/05/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18/11/2023
EX4G
SOU EXTENSION 4 GRANTED
16/11/2023
EXT4
SOU EXTENSION 4 FILED
16/11/2023
EEXT
SOU TEAS EXTENSION RECEIVED
16/11/2023
DOCK
ASSIGNED TO EXAMINER
13/11/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16/05/2023
EX3G
SOU EXTENSION 3 GRANTED
12/05/2023
EXT3
SOU EXTENSION 3 FILED
12/05/2023
EEXT
SOU TEAS EXTENSION RECEIVED
12/05/2023
DOCK
ASSIGNED TO EXAMINER
02/05/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18/11/2022
EX2G
SOU EXTENSION 2 GRANTED
16/11/2022
EXT2
SOU EXTENSION 2 FILED
16/11/2022
EEXT
SOU TEAS EXTENSION RECEIVED
16/11/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
14/05/2022
EX1G
SOU EXTENSION 1 GRANTED
12/05/2022
EXT1
SOU EXTENSION 1 FILED
12/05/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/05/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
16/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/09/2021
PUBO
PUBLISHED FOR OPPOSITION
21/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/09/2021
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
17/08/2021
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
13/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/07/2021
ALIE
ASSIGNED TO LIE
09/07/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
26/05/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
22/04/2021
GNSL
LETTER OF SUSPENSION E-MAILED
22/04/2021
CNSL
SUSPENSION LETTER WRITTEN
22/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/03/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/03/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/09/2020
GNRT
NON-FINAL ACTION E-MAILED
22/09/2020
CNRT
NON-FINAL ACTION WRITTEN
22/09/2020
DOCK
ASSIGNED TO EXAMINER
22/09/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/07/2020
NWAP
NEW APPLICATION ENTERED
22/06/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace QVEQLI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.